Emeryville, CA – According to filings with the U.S. Securities and Exchange Commission, NovaBay Pharmaceuticals is raising $2,400,000.00 in a new round of investment. Sources indicate as part of senior management President and Chief Executive Officer, Justin Hall played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market. We are currently focused primarily on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States.

To learn more about NovaBay Pharmaceuticals, visit http://novabay.com/

Contact:
Justin Hall, President and Chief Executive Officer
510-899-8800
jhall@novabay.com
https://www.linkedin.com/in/justinesq/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved